Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,894 | 10,391 | 12,205 | 14,231 | 20,945 |
| Marketable Securities | 51,435 | 67,337 | 78,211 | 92,673 | 107,458 |
| Receivables | N/A | N/A | 3,000 | N/A | N/A |
| TOTAL | $72,105 | $83,073 | $99,956 | $111,871 | $132,440 |
| Non-Current Assets | |||||
| PPE Net | 7,997 | 8,460 | 8,924 | 9,403 | 9,899 |
| Intangibles | 0 | 2,434 | 2,488 | 2,544 | 2,600 |
| Other Non-Current Assets | 11,418 | 11,637 | 11,847 | 12,049 | 12,242 |
| TOTAL | $19,415 | $22,531 | $23,259 | $23,996 | $24,741 |
| Total Assets | $91,520 | $105,604 | $123,215 | $135,867 | $157,181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,885 | 9,756 | 9,412 | 2,846 | 4,859 |
| Accrued Expenses | 8,554 | 7,996 | 6,698 | 10,076 | 11,371 |
| TOTAL | $21,131 | $19,382 | $17,678 | $14,430 | $17,680 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16,981 | 17,443 | 17,894 | 18,334 | 18,750 |
| TOTAL | $16,981 | $17,443 | $17,894 | $18,334 | $18,750 |
| Total Liabilities | $38,112 | $36,825 | $35,572 | $32,764 | $36,430 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,831 | 62,264 | 62,018 | 61,948 | 61,590 |
| Common Shares | 63 | 62 | 62 | 62 | 60 |
| Retained earnings | -443,177 | -425,071 | -403,068 | -384,714 | -363,556 |
| Other shareholders' equity | 53 | 69 | -5 | 49 | 170 |
| TOTAL | $53,408 | $68,779 | $87,643 | $103,103 | $120,751 |
| Total Liabilities And Equity | $91,520 | $105,604 | $123,215 | $135,867 | $157,181 |